WHO ICTRP trial
Effect and Safety of preventive Treatment with ACE-Inhibitor and Beta-Blocker on…
DRKS00000115 · German Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | DRKS00000115 |
|---|---|
| Public title | Effect and Safety of preventive Treatment with ACE-Inhibitor and Beta-Blocker on the onset of Left Ventricular Dysfunction in Duchenne Muscular Dystrophy |
| Scientific title | Effect and Safety of preventive Treatment with ACE-Inhibitor and Beta-Blocker on the onset of Left Ventricular Dysfunction in Duchenne Muscular Dystrophy - DMD Kardio |
| Primary sponsor | Friedrich- Alexander- Universität Erlangen Nürnberg, Universitätsklinikum , Dekan |
| Registry | German Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 2-3 |
| Countries | Germany |
| Conditions | I50;Heart failure |
| Interventions | Group 1: run-in period with open up titration of beta-blocker and ACE inhibitor (Metoprolol-Succinat and Enalaprilmaleat) over 4x4 weeks with consideration of weight, oral application. Tablets with following dose: Metoprolol-Succinat: 23,75… |
| Registration date | Nov 18, 2009 |
| Target size | 55 |
| Secondary IDs | U1111-1112-2933;2009-009871-36;4035573 |
| Registry page | drks.de |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: